Analogous events occur in EGFR-mutant LUAD, where prolonged TKI treatment can lead to transformation into small-cell lung cancer (SCLC) or, less commonly, squamous cell carcinoma (SCC) [15,23]. This evidence concerns the gene EGFR and small cell lung carcinoma.